Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Conversion to mycophenolate mofetil from azathioprine shows significant positive effect on graft function in long-term past-kidney transplantation stable-state patients.

Nakazawa S, Kishikawa H, Kawamura M, Ueda N, Hirai T, Nishimura K.

Transplant Proc. 2014;46(2):411-4. doi: 10.1016/j.transproceed.2013.12.038.

PMID:
24655976
2.

A randomized trial with steroids and antithymocyte globulins comparing cyclosporine/azathioprine versus tacrolimus/mycophenolate mofetil (CATM2) in renal transplantation.

Vacher-Coponat H, Moal V, Indreies M, Purgus R, Loundou A, Burtey S, Brunet P, Moussi-Frances J, Daniel L, Dussol B, Berland Y.

Transplantation. 2012 Feb 27;93(4):437-43. doi: 10.1097/TP.0b013e31824215b7.

PMID:
22228415
3.

Randomized trial of tacrolimus plus mycophenolate mofetil or azathioprine versus cyclosporine oral solution (modified) plus mycophenolate mofetil after cadaveric kidney transplantation: results at 2 years.

Ahsan N, Johnson C, Gonwa T, Halloran P, Stegall M, Hardy M, Metzger R, Shield C 3rd, Rocher L, Scandling J, Sorensen J, Mulloy L, Light J, Corwin C, Danovitch G, Wachs M, VanVeldhuisen P, Salm K, Tolzman D, Fitzsimmons WE.

Transplantation. 2001 Jul 27;72(2):245-50.

PMID:
11477347
4.

The impact of mycophenolate mofetil versus azathioprine as adjunctive therapy to cyclosporine on the rates of renal allograft loss due to glomerular disease recurrence.

Pham PT, Pham PC.

Nephrol Dial Transplant. 2012 Jul;27(7):2965-71. doi: 10.1093/ndt/gfr731. Epub 2011 Dec 29.

PMID:
22207327
5.

Prophylaxis of chronic kidney disease after liver transplantation--experience from west China.

Shao ZY, Yan LN, Wang WT, Li B, Wen TF, Yang JY, Xu MQ, Zhao JC, Wei YG.

World J Gastroenterol. 2012 Mar 7;18(9):991-8. doi: 10.3748/wjg.v18.i9.991.

6.

Cyclosporin withdrawal with concomitant conversion from azathioprine to mycophenolate mofetil in renal transplant recipients with chronic allograft nephropathy: a 2-year follow-up.

Ducloux D, Motte G, Billerey C, Bresson-Vautrin C, Vautrin P, Rebibou JM, Saint-Hillier Y, Chalopin JM.

Transpl Int. 2002 Sep;15(8):387-92. Epub 2002 Aug 21.

7.

Randomized trial of tacrolimus + mycophenolate mofetil or azathioprine versus cyclosporine + mycophenolate mofetil after cadaveric kidney transplantation: results at three years.

Gonwa T, Johnson C, Ahsan N, Alfrey EJ, Halloran P, Stegall M, Hardy M, Metzger R, Shield C 3rd, Rocher L, Scandling J, Sorensen J, Mulloy L, Light J, Corwin C, Danovitch G, Wachs M, VanVeldhuisen P, Leonhardt M, Fitzsimmons WE.

Transplantation. 2003 Jun 27;75(12):2048-53.

PMID:
12829910
8.

Randomized trial of conversion from mycophenolate mofetil to azathioprine 6 months after renal allograft transplantation.

Wüthrich RP, Cicvara S, Ambühl PM, Binswanger U.

Nephrol Dial Transplant. 2000 Aug;15(8):1228-31.

PMID:
10910450
9.

Conversion from mycophenolate mofetil to azathioprine in renal allograft [corrected] patients within the first month posttransplantation.

Zhu B, Liu Z, Wu C, Wang P, Wang X, Xu H.

Transplant Proc. 2008 Sep;40(7):2258-61. doi: 10.1016/j.transproceed.2008.06.021.

PMID:
18790207
10.
12.

Mycophenolate mofetil versus azathioprine for prevention of chronic allograft dysfunction in renal transplantation: the MYSS follow-up randomized, controlled clinical trial.

Remuzzi G, Cravedi P, Costantini M, Lesti M, Ganeva M, Gherardi G, Ene-Iordache B, Gotti E, Donati D, Salvadori M, Sandrini S, Segoloni G, Federico S, Rigotti P, Sparacino V, Ruggenenti P.

J Am Soc Nephrol. 2007 Jun;18(6):1973-85. Epub 2007 Apr 25.

13.

Tacrolimus vs. cyclosporine A as primary immunosuppression in pediatric renal transplantation: a NAPRTCS study.

Neu AM, Ho PL, Fine RN, Furth SL, Fivush BA.

Pediatr Transplant. 2003 Jun;7(3):217-22.

PMID:
12756047
14.

A study comparing mycophenolate mofetil to azathioprine in simultaneous pancreas-kidney transplantation.

Odorico JS, Pirsch JD, Knechtle SJ, D'Alessandro AM, Sollinger HW.

Transplantation. 1998 Dec 27;66(12):1751-9.

PMID:
9884272
15.

Mycophenolate mofetil in pancreas transplantation.

Gruessner RW, Sutherland DE, Drangstveit MB, Wrenshall L, Humar A, Gruessner AC.

Transplantation. 1998 Aug 15;66(3):318-23.

PMID:
9721799
16.

The effect of maintenance immunosuppression medication on the change in kidney allograft function.

Gill JS, Tonelli M, Mix CH, Johnson N, Pereira BJ.

Kidney Int. 2004 Feb;65(2):692-9.

18.

Safe conversion of mycophenolate mofetil to azathioprine in kidney transplant recipients with sirolimus-based immunosuppression.

El-Agroudy AE, El-Dahshan KF, Wafa EW, Sheashaa HA, Gad ZA, Ismail AM, Shokeir AA, Ghoneim MA.

Nephrology (Carlton). 2009 Apr;14(2):255-61. doi: 10.1111/j.1440-1797.2008.00988.x.

PMID:
19017277
19.

Rescue immunosuppressive therapies in living-related renal allotransplant: a long-term prospective randomized evaluation.

Bakr MA, Gheith OA, Ismael AM, Baz ME, Shehab El-Dein AB, Ghoneim MA.

Exp Clin Transplant. 2008 Mar;6(1):48-53.

20.

Effect of mycophenolate mofetil on erythropoiesis in stable renal transplant patients is correlated with mycophenolic acid trough levels.

van Besouw NM, van der Mast BJ, Smak Gregoor PJ, Hesse CJ, IJzermans JN, van Gelder T, Weimar W.

Nephrol Dial Transplant. 1999 Nov;14(11):2710-3.

PMID:
10534517

Supplemental Content

Support Center